Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 28.41 | N/A |
| PEG Ratio (TTM) | 0.69 | N/A |
| P/S Ratio (TTM) | 0.67 | N/A |
| P/B Ratio (TTM) | 1.59 | N/A |
| P/FCF Ratio (TTM) | 9.25 | N/A |
| Price to 5YR AVG Earnings Ratio | 36.87 | N/A |
| Price to 5YR AVG FCF Ratio | 24.36 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.09% | N/A |
| ROE (TTM) | 5.65% | N/A |
| Net Profit Margin (TTM) | 2.12% | N/A |
| ROIC 5YR AVG | 4.77% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 41.34% | 270.98% | 179.39% |
| Revenue | 1.71% | 5.46% | 9.74% |
| Net Income | 37.11% | 283.79% | 189.36% |
| Cash Flow | 109.81% | 69.96% | 746.60% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.44 | N/A |
| Quick Ratio (TTM) | 0.79 | N/A |
| D/E Ratio (TTM) | 0.15 | N/A |
| Interest Coverage (TTM) | 5.70 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 3.33 | N/A |
| LTL to 5YR AVG FCF | 1.89 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.91% | N/A |